Type
Closure
Country
Ireland
Region
Border; Midland and Western; West
Location of affected unit(s)
Sligo
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

250 jobs
Number of planned job losses
Job loss
Announcement Date
11 November 2009
Employment effect (start)
31 March 2010
Foreseen end date
19 November 2013

Description

Pharmaceutical company Stiefel Laboratories in Sligo is to close by 2013, making 250 workers redundant. The news comes only four months after the company was taken over by pharmaceutical multinational GlaxoSmithKline (GSK). The company, which manufactures a range of skincare products, has attributed the closure to underutilised capacity across Stiefel and GSK operations.

In a statement, Stiefel said that production would continue at the Sligo site until all products are transferred to alternative facilities. While closure is not imminent, there is uncertainty as to when the job losses will commence - it is understood workers could face redundancy in anything from four months to four years' time. Formal employee consultation has commenced in preparation for the transfers, and it is reported that more details will be available by March 2010.


Sources

  • 12 November 2009: The Irish Times

Citation

Eurofound (2009), Stiefel Laboratories, Closure in Ireland, factsheet number 69865, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69865.